Press Releases

ATLANTA, Sept. 5, 2019 /PRNewswire/ -- BioIQ, a healthcare engagement and gap closure company that is redefining the way payers, employers and consumers navigate and connect with the U.S. healthca

NEW YORK, Sept. 5, 2019 /PRNewswire/ -- TMRW, the automated fertility tissue management system for IVF clinics, announced today that Lori Batta has joined the firm as its Chief Commercial Officer.

NEW YORK, Sept. 5, 2019 /PRNewswire/ -- pCare™ has acquired

FORT WORTH, Texas, Sept. 5, 2019 /PRNewswire/ -- LUCIA VISION co-founders Daniel(father) and Liz(daughter) Huber have launched LUCIAEYES.com to raise awareness amongst parents regarding the emerging health impacts triggered by (EBLE).  (EBLE) occurs when individuals are exposed to LED and CFL light bulbs, computers screens, smartphones or tablets for more than

WESTMINSTER, Mass., Sept. 5, 2019 /PRNewswire/ -- Even if you are one of the lucky ones who has not been touched by the scourge of addiction, the loss of so many Massachusetts residents to substance use disorder ("SUD") may propel you to lend a hand now to help in the battle against this deadly disease.

HOUSTON and VANCOUVER, Sept. 5, 2019 /PRNewswire/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer announced the Company will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference on

ROCKVILLE, Md., Sept. 5, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, U.S., and throughout the world, announces it will host a key opinion leader (KOL) symposium addressing innovatio

DUBLIN, Sept. 5, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced  that four new studies of XIAFLEX® (collagenase clostridium histolyticum), including real-world data, for the treatment of Dupuytren's contracture will be presented as ePosters at the 74th Annual Meeting of the American Society for Surgery of the Hand (ASSH) in

BOSTON, Sept. 5, 2019 /PRNewswire/ -- IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, today announced that IFM Due, an IFM subsidiary company, has reached a collaboration and exclusive option agreement with Novartis to develop a suite of immunotherapies that

OLDWICK, N.J., Sept. 5, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that management will present at the H.C. Wainwright 21st Annual Global Investment Conference on Tuesday, September 10, 2019